Terms: = Thyroid cancer AND APC, DP2, 324, ENSG00000134982, P25054, FPC, GS, DP3, DP2_5 AND Prognosis
37 results:
1. Clinicopathological features and prognostic value of CD276 expression in female reproductive system malignancies: A meta-analysis.
Su H; Hao JJ; Xu YB; Zhang FH
Taiwan J Obstet Gynecol; 2024 Mar; 63(2):154-160. PubMed ID: 38485307
[TBL] [Abstract] [Full Text] [Related]
2. Clinical value of multi-gene testing in distinguishing benign and malignant thyroid nodules.
Zhang M; Hu X; Liu L; Wang Y; Jiang J; Li H; Fei W; Zhong T; Jiang Z
Medicine (Baltimore); 2024 Jan; 103(4):e35960. PubMed ID: 38277563
[TBL] [Abstract] [Full Text] [Related]
3. Correlation between second and first primary cancer: systematic review and meta-analysis of 9 million cancer patients.
Wang X; Zeng M; Ju X; Lin A; Zhou C; Shen J; Liu Z; Tang B; Cheng Q; Wang Y; Zhang J; Luo P
Br J Surg; 2024 Jan; 111(1):. PubMed ID: 38055899
[TBL] [Abstract] [Full Text] [Related]
4. APOBEC3C is a novel target for the immune treatment of lower-grade gliomas.
Zhao S; Li Y; Xu J; Shen L
Neurol Res; 2024 Mar; 46(3):227-242. PubMed ID: 38007705
[TBL] [Abstract] [Full Text] [Related]
5. A long-term retrospective cohort-based risk-benefit analysis of augmenting total cumulative I-131 activity to 37GBq in differentiated thyroid cancer patients with skeletal metastases.
Kanankulam Velliangiri S; Ballal S; Prasad Yadhav M; Tripathi M; Satapathy S; Bal C
PLoS One; 2023; 18(11):e0294343. PubMed ID: 37963164
[TBL] [Abstract] [Full Text] [Related]
6. Clinical Characteristics and Responses to Immune Checkpoint Inhibitors in RET-Aberrant Digestive Tract Tumours.
Yen CC; Yeh YM; Huang HY; Ting YL; Fu PA; Lin TC; Liu IT; Yen CJ
Target Oncol; 2023 Jul; 18(4):611-623. PubMed ID: 37347391
[TBL] [Abstract] [Full Text] [Related]
7. The other colon cancer: a population-based cohort study of appendix tumour trends and prognosis.
Halfter K; Schubert-Fritschle G; Klauschen F; Werner J; Mayerle J; Weichert W; Friess H; Schmid R; Kremer M; Ruppert R; Hoelzl J; Krenz D; Nerlich A; Agha A; Fuchs M; Becker I; Nowak K; Engel J; Schlesinger-Raab A
Colorectal Dis; 2023 May; 25(5):943-953. PubMed ID: 36748436
[TBL] [Abstract] [Full Text] [Related]
8. cancer incidence and mortality in Quito: information to monitor cancer control policies.
Cueva P; Tarupi W; Caballero H
Colomb Med (Cali); 2022; 53(1):e2024929. PubMed ID: 36415599
[TBL] [Abstract] [Full Text] [Related]
9. Cribriform - morular thyroid carcinoma: a rare entity.
Michnová U; Traboulsi E; Peková B; Ryška A
Cesk Patol; 2022; 58(2):107-110. PubMed ID: 35882545
[TBL] [Abstract] [Full Text] [Related]
10. Association between the type of thyroid dysfunction induced by immune checkpoint inhibitors and prognosis in cancer patients.
Baek HS; Jeong C; Shin K; Lee J; Suh H; Lim DJ; Kang MI; Ha J
BMC Endocr Disord; 2022 Apr; 22(1):89. PubMed ID: 35379219
[TBL] [Abstract] [Full Text] [Related]
11. Central Compartment Lymph Nodes Have Distinct Metastatic Patterns in Different Age Groups.
Yan C; He X; Chen Z; Wang Y
Front Endocrinol (Lausanne); 2022; 13():807431. PubMed ID: 35250865
[TBL] [Abstract] [Full Text] [Related]
12. Incidence and prognosis of thyroid cancer in children: based on the SEER database.
Zhang B; Wu W; Shang X; Huang D; Liu M; Zong L
Pediatr Surg Int; 2022 Mar; 38(3):445-456. PubMed ID: 35091762
[TBL] [Abstract] [Full Text] [Related]
13. New Perspectives on the Recurrent Monoallelic Germline Mutations of DNA Repair and Checkpoint Genes and Clinical Variability.
Sahin I; Saat H
Genet Test Mol Biomarkers; 2022 Jan; 26(1):17-25. PubMed ID: 35089076
[No Abstract] [Full Text] [Related]
14. Retrospective study of the influence of hypothyroidism on liver function before radioiodine therapy in China: a comparison analysis based on patients with differentiated thyroid cancer.
Ji Y; Zheng W; Meng Z; Wu C; Tan J; Wang R
BMJ Open; 2022 Jan; 12(1):e045562. PubMed ID: 35042702
[TBL] [Abstract] [Full Text] [Related]
15. Incidence and outcomes of malignant ovarian germ cell tumors in Korea, 1999-2017.
Park M; Lim J; Lee JA; Park HJ; Park BK; Lim MC; Park SY; Won YJ
Gynecol Oncol; 2021 Oct; 163(1):79-84. PubMed ID: 34392955
[TBL] [Abstract] [Full Text] [Related]
16. Incidence and prognostic factors of primary thyroid lymphoma and construction of prognostic models for post-chemotherapy and postoperative patients: a population-based study.
Xiang N; Dong F; Zhan X; Wang S; Wang J; Sun E; Chen B
BMC Endocr Disord; 2021 Apr; 21(1):68. PubMed ID: 33849490
[TBL] [Abstract] [Full Text] [Related]
17. Medulloblastoma and familial adenomatous polyposis: Good prognosis and good quality of life in the long-term?
Massimino M; Signoroni S; Boschetti L; Chiapparini L; Erbetta A; Biassoni V; Schiavello E; Ferrari A; Spreafico F; Terenziani M; Chiaravalli S; Puma N; Bergamaschi L; Ricci MT; Cattaneo L; Gattuso G; Buttarelli FR; Gianno F; Miele E; Poggi G; Vitellaro M
Pediatr Blood Cancer; 2021 Apr; 68(4):e28912. PubMed ID: 33459525
[TBL] [Abstract] [Full Text] [Related]
18. Real-World Efficacy and Safety of Cabozantinib and Vandetanib in Advanced Medullary thyroid cancer.
Koehler VF; Adam P; Frank-Raue K; Raue F; Berg E; Hoster E; Allelein S; Schott M; Kroiss M; Spitzweg C
Thyroid; 2021 Mar; 31(3):459-469. PubMed ID: 32781914
[No Abstract] [Full Text] [Related]
19. Construction and analysis of circular RNA molecular regulatory networks in clear cell renal cell carcinoma.
Ma C; Qin J; Zhang J; Wang X; Wu D; Li X
Mol Med Rep; 2020 Jan; 21(1):141-150. PubMed ID: 31746384
[TBL] [Abstract] [Full Text] [Related]
20. Medulloblastomas associated with an apc germline pathogenic variant share the good prognosis of CTNNB1-mutated medulloblastomas.
Surun A; Varlet P; Brugières L; Lacour B; Faure-Conter C; Leblond P; Bertozzi-Salomon AI; Berger C; André N; Sariban E; Raimbault S; Prieur F; Desseigne F; Zattara H; Guimbaud R; Polivka M; Delisle MB; Vasiljevic A; Maurage CA; Figarella-Branger D; Coulet F; Guerrini-Rousseau L; Alapetite C; Dufour C; Colas C; Doz F; Bourdeaut F
Neuro Oncol; 2020 Jan; 22(1):128-138. PubMed ID: 31504825
[TBL] [Abstract] [Full Text] [Related]
[Next]
